Effect of gastrin receptor blockade on endocrine cells in rats during achlorhydria.
Hyperplasia of the oxyntic enterochromaffinlike cells in response to long-lasting blockade of acid secretion is closely related to hypergastrinemia. In the present study, the effect of a specific gastrin receptor antagonist on proton pump inhibitor-induced changes on serum gastrin levels, mucosal height, as well as gastrin- and enterochromaffin-like cells was investigated in rats. The proton pump inhibitor BY 308 or the vehicle methylcellulose [Methocel (controls)] was administered for 2 weeks in the presence and absence of the gastrin receptor antagonist PD 136450 (CAM 1189). BY 308 significantly increased serum gastrin levels, gastrin cell density, and antral gastrin concentration. Concomitant application of PD 136450 did not alter this response. In the oxyntic stomach, mucosal height, enterochromaffinlike cell density, labeling index of enterochromaffinlike cells, and histamine concentration were elevated after treatment with BY 308. These increases were almost completely abolished by PD 136450. Even in normogastrinemic control rats, PD 136450 significantly decreased mucosal height of the oxyntic part of the stomach and the labeling index of enterochromaffinlike cells. The results show that (a) trophic effects of drug-induced achlorhydria are mediated by gastrin; (b) even in control rats (normogastrinemic), gastrin is a trophic factor for the oxyntic mucosa; and (c) antral gastrin cell hyperplasia in states of chronic achlorhydria is not mediated by gastrin itself.
Eissele
R
R
Department of Medicine, Philipps University, Marburg, Germany.
Patberg
H
H
Koop
H
H
Krack
W
W
Lorenz
W
W
McKnight
A T
AT
Arnold
R
R
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000126:Achlorhydria / Q000188:drug therapy* / Q000473:pathology*; D000818:Animals; D004759:Enterochromaffin Cells / Q000166:cytology* / Q000378:metabolism*; D005755:Gastrins / Q000032:analysis; D006632:Histamine / Q000032:analysis; D007211:Indoles / Q000494:pharmacology*; D008297:Male; D009853:Omeprazole / Q000031:analogs & derivatives / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology*; D017494:Proton Pumps / Q000502:physiology; D011863:Radioimmunoassay; D051381:Rats; D017207:Rats, Sprague-Dawley; D011949:Receptors, Cholecystokinin / Q000502:physiology*; D013270:Stomach / Q000473:pathology*; D013997:Time Factors
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D005755:Gastrins; D007211:Indoles; D010627:Phenethylamines; D017494:Proton Pumps; D011949:Receptors, Cholecystokinin; C077645:PD 136450; D006632:Histamine; C049708:B 823-08; D009853:Omeprazole